SCHEMBL2063095

SCHEMBL2063095

CC(C)(O)c1cccc(-c2ccc3nc(-c4ccc(Cl)cc4)cn3c2)c1Cl

nearest known ligand 0.64

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
NR4A2 P43354 8/20 0.64
KCNH2 Q12809 2/20 0.64
ALDH1A1 P00352 6/20 0.54
ALDH1A3 P47895 4/20 0.54
NPC1 O15118 6/20 0.53
RAB9A P51151 6/20 0.53
CYP2C9 P11712 1/20 0.51
APP P05067 1/20 0.46
ALDH1A2 O94788 1/20 0.44
SLC2A1 P11166 1/20 0.43
KDM4E B2RXH2 3/20 0.42
SMN1; SMN2 Q16637 3/20 0.42
MAPT P10636 1/20 0.42
PKM P14618 1/20 0.42
NFKB1 P19838 1/20 0.42
NFKB2 Q00653 1/20 0.42
RELA Q04206 1/20 0.42
MEN1 O00255 1/20 0.42
MITF O75030 1/20 0.42
KDM5A P29375 1/20 0.42

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL2064026 0.87 NR4A2 (0.59) NR4A2KCNH2ALDH1A1ALDH1A3NPC1
SCHEMBL2064055 0.80 ALDH1A3 (0.56) NR4A2KCNH2ALDH1A1ALDH1A3NPC1
SCHEMBL2063037 0.79 NR4A2 (0.64) NR4A2KCNH2ALDH1A1ALDH1A3NPC1
SCHEMBL2063041 0.79 NR4A2 (0.56) NR4A2KCNH2ALDH1A1ALDH1A3NPC1
SCHEMBL1472110 0.78 NR4A2 (1.00) NR4A2KCNH2ALDH1A1ALDH1A3NPC1
SCHEMBL2063472 0.76 NR4A2 (0.65) NR4A2KCNH2ALDH1A1ALDH1A3NPC1
SCHEMBL2063933 0.74 NR4A2 (0.76) NR4A2KCNH2ALDH1A1ALDH1A3NPC1
SCHEMBL1472122 0.74 NR4A2 (0.63) NR4A2KCNH2ALDH1A1ALDH1A3NPC1
SCHEMBL1472244 0.73 NR4A2 (0.78) NR4A2KCNH2ALDH1A1ALDH1A3NPC1
SCHEMBL218896 0.73 NR4A2 (0.65) NR4A2KCNH2ALDH1A1ALDH1A3NPC1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 6 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2262803-B1 POLYSUBSTITUTED DERIVATIVES OF 2-ARYL-6-PHENYL-IMIDAZO[L,2-A] PYRIDINES, AND PREPARATION AND THERAPEUTIC USE THEREOF SANOFI SA (FR) 2012-10-17 EP claimed
US-8148370-B2 Polysubstituted derivatives of 2-aryl-6-phenyl-imidazo[1,2-a]pyridines, and preparation and therapeutic use thereof SANOFI-AVENTIS (FR) 2012-04-03 US claimed
US-20110065699-A1 POLYSUBSTITUTED DERIVATIVES OF 2-ARYL-6-PHENYL-IMIDAZO[1,2-a]PYRIDINES, AND PREPARATION AND THERAPEUTIC USE THEREOF SANOFI-AVENTIS (FR) 2011-03-17 US claimed
EP-2262803-B1 POLYSUBSTITUTED DERIVATIVES OF 2-ARYL-6-PHENYL-IMIDAZO[L,2-A] PYRIDINES, AND PREPARATION AND THERAPEUTIC USE THEREOF SANOFI SA (FR) 2012-10-17 EP disclosed
US-8148370-B2 Polysubstituted derivatives of 2-aryl-6-phenyl-imidazo[1,2-a]pyridines, and preparation and therapeutic use thereof SANOFI-AVENTIS (FR) 2012-04-03 US disclosed
US-20110065699-A1 POLYSUBSTITUTED DERIVATIVES OF 2-ARYL-6-PHENYL-IMIDAZO[1,2-a]PYRIDINES, AND PREPARATION AND THERAPEUTIC USE THEREOF SANOFI-AVENTIS (FR) 2011-03-17 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20110065699-A1 POLYSUBSTITUTED DERIVATIVES OF 2-ARYL-6-PHENYL-IMIDAZO[1,2-a]PYRIDINES, AND PREPARATION AND THERAPEUTIC USE THEREOF ABL1, JAK2, REN NR4A2 1531/4885KCNH2 1429/4885ALDH1A1 193/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.